A Novel Approach to Upper Extremity Amputation to Augment Volitional Control and Restore Proprioception
Brigham and Women's Hospital · with Massachusetts Institute of Technology, Walter Reed Army Institute of Research (WRAIR) · NCT03882073
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–65 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 20
- US sites recruiting
- 4
- Study start
- May 1, 2019
- Record last updated
- July 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The hypothesis of this research protocol is that the investigators will be able to redesign the manner in which upper limb amputations are performed so as to enable volitional control of next generation prosthetic devices and restore sensation and proprioception to the amputated limb. The investigators will test this hypothesis by performing modified above elbow or below elbow amputations in ten intervention patients, and compare their outcomes to ten control patients who have undergone tradition amputations at similar levels. The specific aims of the project are:
- To define a standardized approach to the performance of a novel operative procedure for both below elbow (BEA) and above elbow amputations (AEA)
- To measure the degree of volitional motor activation and excursion achievable in the residual limb constructs, and to determine the optimal configuration and design of such constructs
- To describe the extent of proprioceptive feedback achievable through the employment of these modified surgical techniques
- To validate the functional and somatosensory superiority of the proposed amputation technique over standard approaches to BEA and AEA
- To develop a modified acute postoperative rehabilitation strategy suited to this new surgical approach
This will be a phase I/pilot clinical trial to be performed over a three-year period as a collaborative initiative involving Brigham \& Women's Hospital/Brigham \& Women's Faulkner Hospital (BWH/BWFH), Walter Reed National Military Medical Center (WRNMMC), and the Massachusetts Institute of Technology (MIT). The investigators will plan to perform 6 of the 10 amputations at BWH/BWFH, and 4 of the amputations at WRNMMC.
Being studied: Modified amputation procedure; Standard amputation procedure
Conditions: Amputation
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Males or females between the ages of 18 and 65
- Candidates for elective unilateral or bilateral upper extremity amputation at either the above elbow or below elbow level due to traumatic injury, congenital limb deformities or progressive arthritis
- Must demonstrate sufficiently sound health to undergo the operative procedure, including adequate cardiopulmonary stability to undergo general anesthesia (specifically, American Society of Anesthesiology Class I or II)
- Must have intact inherent wound healing capacity
- Must demonstrate adequate communication skills to convey the status of their sensorimotor recovery throughout the postoperative phase,
- Must exhibit proper level of motivation to comply with postoperative follow up requirements
- Must be willing to also consent to study activities taking place at Massachusetts Institute of Technology (approved under same IRB protocol via ceded IRB review) as some outcome measures will be assessed at that site
Exclusion Criteria
- Patients beyond the stated age restrictions
- Those with severe illness rendering them unable to undergo the operative procedure safely (e.g., unresolved sepsis or cardiopulmonary instability manifest as documented coronary artery disease and/or chronic obstructive pulmonary disease)
- Patients with active infections, particularly deep infections in the arm to be amputated
- Patients who are taking immunosuppressive agents
- Patients with impairment in inherent wound healing pathways, such as those with primary connective tissue disorders or those on chronic steroid therapy
- Patients with extensive peripheral neuropathies (diabetic or otherwise) that would potentially inhibit appropriate reinnervation of the surgical constructs
- Active smokers; those patients willing to undergo tobacco cessation will need to be completely abstinent from tobacco use for at least 6 weeks preoperatively
- Patients who are unable to provide informed consent and those with a demonstrated history of poor compliance
- Pregnant women will not be considered due to the potential risks of general anesthesia
Patients will not be excluded from participation in the study on the grounds of minority status, religious status, race or gender. Non-English speaking patients will not be excluded from the study; interpreters will be made available to them for translation of both verbal interactions and written documents.
Recruiting US locations
Walter Reed National Military Medical Center
Bethesda, MD 20889
Site contact: Benjamin K Potter, MD FACS COL MC USA · 3012954290 · benjamin.k.potter.mil@mail.mil
Brigham & Women's Hospital
Boston, MA 02114
Site contact: Matthew J Carty, MD · 6179834522 · mcarty@partners.org
Massachusetts General Hospital
Boston, MA 02114
Site contact: Kyle Eberlin, MD · (617) 643-4902
Massachusetts Institute of Technology Media Lab
Cambridge, MA 02139
Site contact: Hugh Herr, PhD · 6173143661 · hherr@media.mit.edu
Study contacts (from the official record)
- Matthew J Carty, MD · 6179834555 · mcarty@partners.org
Similar studies in Maryland
All healthy volunteers studies in Maryland →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Brooklyn, MD + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 21–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Study of Intravenous ZMA001 in Healthy Subjects
National Heart, Lung, and Blood Institute (NHLBI)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
Johns Hopkins University
- Location
- Baltimore, MD
- Eligibility basics
- Ages 21–55